| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Pantoprazole | FAERS: 23 | US FAERS | |
| 2 | Olmesartan Medoxomil | FAERS: 17 | US FAERS | |
| 3 | Rifaximin | FAERS: 15 | US FAERS | |
| 4 | Finasteride | FAERS: 8 | US FAERS | |
| 5 | Benicar hct | FAERS: 5 | US FAERS | |
| 6 | 2-[(E)-[1-(2-Amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid;(2S)-2,6-diaminohexanoic acid | FAERS: 1 | US FAERS | |
| 7 | Budesonide | FAERS: 1 | US FAERS | |
| 8 | Cholestyramine Resin | FAERS: 1 | US FAERS | |
| 9 | Clonazepam | FAERS: 1 | US FAERS | |
| 10 | Droxidopa | FAERS: 1 | US FAERS | |
| 11 | Estradiol | FAERS: 1 | US FAERS | |
| 12 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 13 | Glatiramer Acetate | FAERS: 1 | US FAERS | |
| 14 | Isotretinoin | FAERS: 1 | US FAERS | |
| 15 | LCZ 696 | FAERS: 1 | US FAERS | |
| 16 | Lamotrigine | FAERS: 1 | US FAERS | |
| 17 | Lenalidomide | FAERS: 1 | US FAERS | |
| 18 | Norethindrone acetate and ethinyl estradiol | FAERS: 1 | US FAERS | |
| 19 | Pantoprazole | FAERS: 1 | US FAERS | |
| 20 | Ranolazine | FAERS: 1 | US FAERS | |
| 21 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 22 | Thyroxine | FAERS: 1 | US FAERS | |
| 23 | apremilast | FAERS: 1 | US FAERS | |
| 24 | glycerol phenylbutyrate | FAERS: 1 | US FAERS | |
| 25 | lanreotide | FAERS: 1 | US FAERS | |
| 26 | teduglutide | FAERS: 1 | US FAERS | |
| 27 | tofacitinib | FAERS: 1 | US FAERS | |
| 28 | Trimebutine | Canada Vigilance: 1 | Canada Vigilance | |
| 29 | ledipasvir, sofosbuvir drug combination | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.